Pilot study of a community pharmacist led program to treat hepatitis C virus among people who inject drugs.

ABSTRACT:

Background

People who inject drugs (PWID) are a key population for treatment with direct-acting antiviral medications (DAAs) to eliminate hepatitis C virus (HCV). We developed a Pharmacist, Physician, and Patient Navigator Collaborative Care Model (PPP-CCM) for delivery of HCV treatment; this study describes clinical outcomes related to HCV treatment (initial evaluation, treatment initiation, completion, and cure), as well as patient satisfaction.

Methods

We conducted a single-arm prospective pilot study of adult PWID living with HCV. Participants completed baseline and six-month follow-up surveys, and treatment and outcomes were abstracted from electronic health records. Primary outcome was linkage to pharmacist for HCV evaluation; secondary outcomes included DAA initiation

SUBMITTER: Tsui JI 

PROVIDER: S-EPMC10796962 | biostudies-literature | 2024 Mar

REPOSITORIES: biostudies-literature